Predictors of Early Polymetastatic Relapse After SABR for up to 5 Oligometastases: A Secondary Analysis of the Phase II SABR-5 Trial

Sarah Baker,Benjamin Mou,Will Jiang,Mitchell Liu,Alanah M Bergman,Devin Schellenberg,Abraham S Alexander,Hannah Carolan,Siavash Atrchian,Tanya Berrang,Andrew Bang,Nick Chng,Quinn Matthews,Scott Tyldesley,Robert A Olson

International Journal of Radiation Oncology*Biology*Physics（2022）

引用 2|浏览22

暂无评分

摘要

Four distinct risk groups for early PMR are identified, which differ significantly in PMR-free survival and overall survival. The group with all 3 risk factors had a median PMR-free survival of 5 months and may not benefit from local ablative therapy alone. This model should be externally validated with data from other prospective trials.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要